Bnp Paribas Asset Management Holding S.A. Global Blood Therapeutics, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $21.6 Million - $45.4 Million	-666,220 Reduced 70.05%	284,891 $19.4 Million
Q2 2022 Aug 04, 2022	BUY	$22.3 - $37.39 $6.87 Million - $11.5 Million	308,207 Added 47.94%	951,111 $30.4 Million
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $6.22 Million - $8.62 Million	242,117 Added 60.41%	642,904 $22.3 Million
Q4 2021 Feb 09, 2022	BUY	$24.9 - $40.26 $2.16 Million - $3.49 Million	86,714 Added 27.61%	400,787 $11.7 Million
Q3 2021 Nov 08, 2021	SELL	$25.48 - $37.34 $7 Million - $10.3 Million	-274,848 Reduced 46.67%	314,073 $8 Million
Q2 2021 Aug 05, 2021	BUY	$32.46 - $43.42 $1.69 Million - $2.26 Million	52,099 Added 9.71%	588,921 $20.6 Million
Q1 2021 May 05, 2021	BUY	$38.94 - $50.85 $10.9 Million - $14.2 Million	278,667 Added 107.95%	536,822 $21.9 Million
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $1.6 Million - $2.71 Million	-42,558 Reduced 14.15%	258,155 $11.2 Million
Q3 2020 Nov 09, 2020	BUY	$52.76 - $74.49 $3.52 Million - $4.97 Million	66,695 Added 28.5%	300,713 $16.6 Million
Q2 2020 Aug 04, 2020	BUY	$48.73 - $81.82 $11.4 Million - $19.1 Million	234,018 New	234,018 $14.8 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.